Results 161 to 169 of about 2,019 (169)

Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics

Clinical Microbiology Reviews
SUMMARY Henipaviruses were first identified 30 years ago and have since been associated with over 30 outbreaks of disease in humans. Highly pathogenic henipaviruses include Hendra virus (HeV) and Nipah virus (NiV), classified as biosafety level 4 pathogens.
Jessica R. Spengler, Michael K. Lo, Stephen R. Welch, Christina F. Spiropoulou   +3 more
openaire   +2 more sources

Medical countermeasures against henipaviruses: a review and public health perspective

Lancet Infectious Diseases, The, 2022
Raúl Gomez Roman, Amy C Shurtleff
exaly  

Broad-Spectrum Vaccines & Therapeutics for Henipaviruses

2021
openaire   +2 more sources

A trial for post-exposure prophylaxis against henipaviruses

The Lancet Infectious Diseases, 2020
openaire   +2 more sources

4′-Azidocytidine (R1479) inhibits henipaviruses and other paramyxoviruses with high potency

Antiviral Research, 2017
Biao He, Christina Spiropoulou, Anne Hotard   +2 more
exaly  

Henipaviruses: An Updated Review Focusing on the Pteropid Reservoir and Features of Transmission

Zoonoses and Public Health, 2013
Glenn A Marsh
exaly  

Henipaviruses and Other Miscellaneous Pathogens

2020
openaire   +1 more source

Host cell recognition by the henipaviruses: Crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3

Proceedings of the National Academy of Sciences of the United States of America, 2008
Christopher Broder, Kai Xu, Dimitar Nikolov   +2 more
exaly  

Emergence and ecology of zoonotic henipaviruses

2007
openaire   +1 more source